From a review of SEC filings, below are the Gold-Standard US GAAP Pretax Income (Loss) From Continuing Operations for these 10 San Diego City Companies in each of the December, the September and the June quarters of both 2019 and 2018.
` | US | US | US | US | US | US | |||||
GAAP | GAAP | GAAP | GAAP | GAAP | GAAP | ||||||
Pretax | Pretax | Pretax | Pretax | Pretax | Pretax | ||||||
Income | Income | Income | Income | Income | Income | ||||||
(Loss) | (Loss) | (Loss) | (Loss) | (Loss) | (Loss) | ||||||
Dec | Dec | Sept | Sept | June | June | ||||||
City of San Diego Smaller Companies | California | Quarter | Quarter | Quarter | Quarter | Quarter | Quarter | ||||
Market Caps $2 Bil to $10 Bil | City HQs | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | ||||
mils $ | mils $ | mils $ | mils $ | mils $ | mils $ | ||||||
Acadia Pharmaceuticals | San Diego | (53) | (65) | (42) | (62) | (55) | (63) | ||||
Nuvasive | San Diego | 33 | 16 | 16 | 13 | 21 | 16 | ||||
Quidel Corp | San Diego | 33 | 23 | 18 | 11 | 1 | (9) | ||||
AMN Health Services | San Diego | 38 | 50 | 32 | 38 | 39 | 48 | ||||
Cubic Corp | San Diego | (10) | (8) | 52 | 26 | 22 | 5 | ||||
Arena Pharmaceuticals | San Diego | (88) | (42) | (73) | (34) | (61) | (32) | ||||
Halozyme Therapeutics | San Diego | (34) | (2) | (25) | (28) | (15) | (23) | ||||
Mirati Therapeutics | San Diego | (72) | (28) | (54) | (28) | (46) | (28) | ||||
PriceSmart | San Diego | 29 | 22 | 32 | 26 | 22 | 27 | ||||
WD-40 Co | San Diego | 14 | 16 | 22 | 19 | 36 | 37 | ||||
Total all 10 Smaller City of San Diego Cos | (110) | (18) | (22) | (19) | (36) | (22) | |||||
….. % Change From Prior Year Quarter | -511% | -16% | -64% | ||||||||
Total Pretax Income (Loss) | |||||||||||
….. Nine Months Ended December 2019 | (168) | ||||||||||
….. Nine Months Ended December 2018 | (59) | ||||||||||
………. % Decline | -185% |